Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report)’s stock price shot up 5.8% during mid-day trading on Monday . The stock traded as high as $2.36 and last traded at $2.36. Approximately 234,559 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 1,004,176 shares. The stock had previously […]
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report)’s share price traded down 7.5% during mid-day trading on Wednesday . The stock traded as low as $2.32 and last traded at $2.33. 283,291 shares were traded during trading, a decline of 71% from the average session volume of 961,310 shares. The stock had previously closed at […]
Baillie Gifford & Co. lessened its stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 3.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 732,636 shares of the company’s stock after selling 28,685 shares during the period. Baillie Gifford & […]
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report) traded up 6.6% on Monday . The stock traded as high as $2.03 and last traded at $2.03. 740,615 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 1,368,029 shares. The stock had previously closed at $1.90. Wall Street Analysts […]
TD Asset Management Inc grew its position in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 140.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 431,916 shares of the company’s stock after purchasing an additional 252,227 shares during the quarter. TD […]